Abel Hall »

C4 Therapeutics shares owned by Abel Hall

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Abel Hall from 13F filings

Historical chart of Abel Hall investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Abel Hall consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Abel Hall

Quarter filed Position value Share count Share price at filing
2025-09-30 $23k 10k 2.22
2025-06-30 $15k 10k 1.43

More positions owned by Abel Hall

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Intl Small Cap V (DISV)
Apple (AAPL)
Dimensional Etf Trust Intl High Profit (DIHP)
Amazon (AMZN)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Dimensional Etf Trust Global Core Plus (DFGP)
Exxon Mobil Corporation (XOM)

View all positions for Abel Hall

Top funds holding C4 Therapeutics

Lynx1 Capital Management
Soleus Capital Management
OrbiMed Advisors
Daniel D. Thurber
Morgan Stanley
Vanguard Group
Millennium Management
Silverarc Capital Management
BlackRock
Bain Capital Life Sciences Investors
Renaissance Technologies
Tang Capital Management
Two Sigma Investments
Two Sigma Advisers
Geode Capital Management

View all funds holding C4 Therapeutics